Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geng Liu

Showing results (241-250 of 378) with videos related to

Pageof 38
Sort By:
Signal Transduction and Targeted Therapy|May 2, 2024
Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoringNingyuan Wen, Dingzhong Peng, Xianze Xiong, et al.
Chinese Journal of Integrative Medicine|May 14, 2015
Effects of Hedan Tablet () on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary studyRui-Xia Xu, Na-Qiong Wu, Sha Li, et al.
Plos One|April 28, 2023
TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cellsZhenyu Qiu, Shouqing Guo, Geng Liu, et al.
Postgraduate Medical Journal|July 19, 2019
Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort studyShuo-Lin Liu, Na-Qiong Wu, Yuan-Lin Guo, et al.
Journal of Diabetes and Its Complications|October 21, 2015
Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery diseaseSha Li, Yan Zhang, Yuan-Lin Guo, et al.
Biomedical and Environmental Sciences : BES|March 2, 2017
Plasma apoCIII Levels in Relation to Inflammatory Traits and Metabolic Syndrome in Patients not Treated with Lipid-lowering Drugs Undergoing Coronary AngiographyNa Qiong Wu, Sha Li, Yan Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 15, 2006
[Randomized controlled trial of two kinds of home-produced docetaxel in China for advanced breast cancer]Dong-Geng Liu, Rou-Jun Peng, Feng-Yi Feng, et al.
Water Research|August 29, 2022
Simulation of experimental synthetic DNA tracer transport through the vadose zoneChaozi Wang, Geng Liu, Coy P McNew, et al.
Chinese Medical Journal|February 19, 2014
Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fractionNaqiong Wu, Fenglian Ma, Yuanlin Guo, et al.
Oncogene|October 22, 2022
UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitinationMeilin Ma, Changhui Zhang, Rong Cao, et al.
Pageof 38

Showing results (241-250 of 378) with videos related to

Sort By:
Pageof 38
Signal Transduction and Targeted Therapy|May 2, 2024
Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoringNingyuan Wen, Dingzhong Peng, Xianze Xiong, et al.
Chinese Journal of Integrative Medicine|May 14, 2015
Effects of Hedan Tablet () on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary studyRui-Xia Xu, Na-Qiong Wu, Sha Li, et al.
Plos One|April 28, 2023
TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cellsZhenyu Qiu, Shouqing Guo, Geng Liu, et al.
Postgraduate Medical Journal|July 19, 2019
Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort studyShuo-Lin Liu, Na-Qiong Wu, Yuan-Lin Guo, et al.
Journal of Diabetes and Its Complications|October 21, 2015
Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery diseaseSha Li, Yan Zhang, Yuan-Lin Guo, et al.
Biomedical and Environmental Sciences : BES|March 2, 2017
Plasma apoCIII Levels in Relation to Inflammatory Traits and Metabolic Syndrome in Patients not Treated with Lipid-lowering Drugs Undergoing Coronary AngiographyNa Qiong Wu, Sha Li, Yan Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 15, 2006
[Randomized controlled trial of two kinds of home-produced docetaxel in China for advanced breast cancer]Dong-Geng Liu, Rou-Jun Peng, Feng-Yi Feng, et al.
Water Research|August 29, 2022
Simulation of experimental synthetic DNA tracer transport through the vadose zoneChaozi Wang, Geng Liu, Coy P McNew, et al.
Chinese Medical Journal|February 19, 2014
Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fractionNaqiong Wu, Fenglian Ma, Yuanlin Guo, et al.
Oncogene|October 22, 2022
UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitinationMeilin Ma, Changhui Zhang, Rong Cao, et al.
Pageof 38